Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
Status:
Recruiting
Trial end date:
2025-02-28
Target enrollment:
Participant gender:
Summary
The goal of this study is to develop novel treatments for patients with a condition called
hypogonadotropic hypogonadism (HH) through the use of exogenous kisspeptin.